In addition to developmental contexts, ERK signalling has also been reported to induce FOS gene expression downstream of oncogenic lesions, such as activating mutations in the BRAF gene, which frequently occur in in human melanomas [51,52,53,54]. This evidence concerns the gene FOS and melanoma.